Ticker League

Revenue for Alnylam Pharmaceuticals (ALNY)

Latest filings through · Reported

Metric

TTM

$4.29B

YoY change

+65.2%

5Y CAGR

+49.8%

Peak year (2025)

$3.71B

Revenue history chart for Alnylam Pharmaceuticals (ALNY) from 2002 to 2025

Latest: $3.71B

Revenue growth chart for Alnylam Pharmaceuticals (ALNY) from 2002 to 2025

Latest: +65.2%

Revenue history table for Alnylam Pharmaceuticals (ALNY) from 2002 to 2025

  • 2025$3.71B+65.2%
  • 2024$2.25B+23.0%
  • 2023$1.83B+76.2%
  • 2022$1.04B+22.9%
  • 2021$844.29M+71.3%
  • 2020$492.85M+124.3%
  • 2019$219.75M+193.4%
  • 2018$74.91M-16.7%
  • 2017$89.91M+90.7%
  • 2016$47.16M+14.8%
  • 2015$41.10M-18.7%
  • 2014$50.56M+7.2%
  • 2013$47.17M-29.3%
  • 2012$66.72M-19.4%
  • 2011$82.76M-17.3%
  • 2010$100.04M-0.5%
  • 2009$100.53M+4.5%
  • 2008$96.16M+88.9%
  • 2007$50.90M+89.0%
  • 2006$26.93M+371.1%
  • 2005$5.72M+33.6%
  • 2004$4.28M+2330.7%
  • 2003$176.00K—
  • 2002$0.00—

Revenue values are taken from Alnylam Pharmaceuticals's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Revenue at Alnylam Pharmaceuticals (ALNY)

According to Alnylam Pharmaceuticals's latest reported financial statements, the company's current revenue (TTM) is $4.29B. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

The 2025 reading of Alnylam Pharmaceuticals (ALNY) revenue is $3.71B – surged 65.2% year-over-year.

Looking at the 2020–2025 (5 years) stretch, Alnylam Pharmaceuticals revenue compounded at +49.8% per year, sustaining 7 straight years of year-over-year growth.

Across the available history, revenue reached its high of $3.71B in 2025 and its low of $0.00 in 2002.

Alnylam Pharmaceuticals Revenue by Year

Alnylam Pharmaceuticals Revenue 2025: $3.71B

2025's revenue for Alnylam Pharmaceuticals came in at $3.71B, surged 65.2% from 2024. This figure represents the highest annual value in the available history.

Alnylam Pharmaceuticals Revenue 2024: $2.25B

Alnylam Pharmaceuticals posted revenue of $2.25B in 2024, grew 23.0% from 2023.

Alnylam Pharmaceuticals Revenue 2023: $1.83B

In 2023, Alnylam Pharmaceuticals reported revenue of $1.83B, surged 76.2% from 2022.

Alnylam Pharmaceuticals Revenue 2022: $1.04B

Alnylam Pharmaceuticals revenue in 2022 was $1.04B, grew 22.9% from 2021.

Alnylam Pharmaceuticals Revenue 2021: $844.29M

Alnylam Pharmaceuticals revenue in 2021 was $844.29M.

See more financial history for Alnylam Pharmaceuticals (ALNY).

Sector peers by Revenue

Healthcare peers of Alnylam Pharmaceuticals (ALNY), ranked by their latest revenue

Frequently asked questions

Alnylam Pharmaceuticals (ALNY) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Capital Return